La ferritina sérica: más allá de la deficiencia de hierro

  • Germán Campuzano-Maya Laboratorio Clínico Hematológico


Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Germán Campuzano-Maya, Laboratorio Clínico Hematológico

Médico, especialista en Hematología y Patología Clínica. Docente Ad Honorem, Facultad de Medicina, Universidad de Antioquia. Coordinador Grupo de Investigación en Patología Clínica. Médico Director, Laboratorio Clínico Hematológico. Medellín, Colombia.

Referencias bibliográficas

Ogilvie C, Fitzsimons K, Fitzsimons EJ. Serum ferritin values in primary care: are high values overlooked? J Clin Pathol 2010;63:1124-1126.

Ho CH. The differential diagnostic values of serum transferrin receptor, serum ferritin and related parameters in the patients with various causes of anemia. Haematologica 2001;86:206-207.

Birgegard G, Hallgren R, Killander A, Stromberg A, Venge P, Wide L. Serum ferritin during infection. A longitudinal study. Scand J Haematol 1978;21:333-340.

Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P, Grady RW, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells 1997;15:291-296.

Seyhan S, Pamuk ON, Pamuk GE, Cakir N. The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus. Eur J Rheumatol 2014;1:92-95.

Thachil J. The beneficial effect of acute phase increase in serum ferritin. Eur J Intern Med 2016;35:e16-e17.

Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-97.

Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.

Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006;23:149-160.

Wu J, Chen L, Chen Y, Yang J, Wu D. Serum ferritin concentration predicts mortality in patients with hepatitis B virus-related acute on chronic liver failure. Arch Med Res 2014;45:251-256.

Ferrara F, Ventura P, Vegetti A, Guido M, Abbati G, Corradini E, et al. Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. Am J Gastroenterol 2009;104:605-616.

Uchino K, Tateishi R, Fujiwara N, Minami T, Sato M, Enooku K, et al. Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients. Hepatol Res 2016;46:259-268.

McLaren GD, Gordeuk VR. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program 2009;195-206.

Mathurin P, Beuzin F, Louvet A, Carrie-Ganne N, Balian A, Trinchet JC, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007;25:1047-1054.

Carithers RL, McClain CJ. Alcoholic liver disease. In: Sleisenger and Fordtran's Gastrointestinal and liver disease pathophysiology diagnosis management, edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia: Saunders Elsevier, 2016, p. 1409-1427.

Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, et al. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 2011;60:80-87.

Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep 2014;14:488.

Campuzano-Maya G. Estudio del paciente con hiperferritinemia. Medicina & Laboratorio 2017;23:411-442.

Cómo citar
Campuzano-Maya G. La ferritina sérica: más allá de la deficiencia de hierro. Med. Lab. [Internet]. 1 de septiembre de 2017 [citado 29 de enero de 2023];23(9-10):409-10. Disponible en:
Crossref Cited-by logo
QR Code